← All trials
NCT01380015
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2011
- Primary completion
- Nov 30, 2012
- Completion date
- Dec 31, 2012
- First posted
- Jun 27, 2011
- Last posted
- Jan 23, 2013
- Enrollment
- 49
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of GuelphLead sponsor
- Government of OntarioCollaborator
- University of GuelphReponsible party - principal investigator
- University of GuelphSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.